PATENT CLAIM ANALYSIS

Application Number: 15958292
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["424", "009100"]

Abstract:
The present disclosure relates to branched and linear chimeric compounds containing both nucleic acid and non-nucleic acid moieties, as well as to polynucleotides. The present disclosure also relates to uses thereof for stimulating an immune response, and to methods for preparation of the branched chimeric compounds.

Claim (Index 32):
The method of  claim 30 , wherein when the pharmaceutical composition further comprises an antigen, stimulating an immune response comprises inducing an antigen-specific antibody response, wherein titer of the antigen-specific antibody response is higher when the antigen is administered in combination with the linear chimeric compound than when the antigen is administered without the linear chimeric compound.

Metadata:
- Claim Count in Document: 53.0
- Percentile: 91.0
- Lexical Diversity: 1.51515
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15004860', '15958295', '13349515', '14030975', '11590150']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8088219626381283
- 35 USC 102 Novelty (BERT): 0.6624470427198984
- Combined Prediction Score: 0.7941844706463054
- Mean Citation Score: 477.34274600000015
- Max Citation Score: 770.35956
- Similarity Product: 603.3942072755958

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test